206 related articles for article (PubMed ID: 7166751)
21. Bestatin treatment for the correction of granulocyte dysfunction in patients with recurrent furunculosis.
Mattsson L; Blomgren H; Holmgren B; Jarstrand C
Infection; 1983; 11(4):205-7. PubMed ID: 6618675
[TBL] [Abstract][Full Text] [Related]
22. Do tuftsin and bestatin constitute a biopharmacological immunoregulatory system?
Mathé G
Cancer Detect Prev Suppl; 1987; 1():445-55. PubMed ID: 3319151
[TBL] [Abstract][Full Text] [Related]
23. [Phase I study of Bestatin: (I) A clinical study on determination of an optimal dose of Bestatin].
Saito K; Miyasato H; Tajima K; Ikeda S
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):211-7. PubMed ID: 6881973
[TBL] [Abstract][Full Text] [Related]
24. The effect of salicylate on human leucocyte migration.
Kemp AS; Smith J
Clin Exp Immunol; 1982 Jul; 49(1):233-8. PubMed ID: 6181922
[TBL] [Abstract][Full Text] [Related]
25. A quantitative and qualitative study of blood monocytes in smokers.
Nielsen H
Eur J Respir Dis; 1985 May; 66(5):327-32. PubMed ID: 3894043
[TBL] [Abstract][Full Text] [Related]
26. [The effects of plant preparations on cellular functions in body defense].
Wildfeuer A; Mayerhofer D
Arzneimittelforschung; 1994 Mar; 44(3):361-6. PubMed ID: 8192704
[TBL] [Abstract][Full Text] [Related]
27. Administration of thymopentin to patients with phobic disorders improves depressed phagocytic functions.
Covelli V; Munno I; Altamura M; Pellegrino NM; Decandia P; Jirillo E
Immunopharmacol Immunotoxicol; 1990; 12(4):619-31. PubMed ID: 2092042
[TBL] [Abstract][Full Text] [Related]
28. In vitro response of phagocytic cells to immunomodulating agents.
Stoika R; Kashchak N; Lutsik-Kordovsky M; Boyko M; Tsyrulnyk A
Med Sci Monit; 2001; 7(4):652-8. PubMed ID: 11433191
[TBL] [Abstract][Full Text] [Related]
29. Function of monocytes in patients with systemic sclerosis.
Czirják L; Dankó K; Zeher M; Lukács K; Szegedi G
Acta Med Hung; 1988; 45(1):53-61. PubMed ID: 3045745
[TBL] [Abstract][Full Text] [Related]
30. [Initial results of the clinical use of the immunostimulant bestatin (3-amino-2-hydroxy-4-phenylbutyryl leucine) in patients with chronic polyarthritis].
Meske S; Vogt P; Maly FE; Seitz M; Müller W
Z Rheumatol; 1985; 44(5):231-6. PubMed ID: 4082790
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of macrolides on human phagocytic functions.
Fietta A; Bersani C; Santagada T; Bertoletti R; Gialdroni Grassi G
Chemioterapia; 1987 Feb; 6(1):52-6. PubMed ID: 3829136
[TBL] [Abstract][Full Text] [Related]
32. Increased reduction of nitroblue tetrazolium by human blood monocytes following post-operative radiation therapy for breast cancer.
Jarstrand C; Petrini B; Wasserman J; Blomgren H; Strender LE
Anticancer Res; 1982; 2(4):209-12. PubMed ID: 7149650
[TBL] [Abstract][Full Text] [Related]
33. Fibronectin increases the motility, phagocytosis and NBT (nitroblue tetrazolium)-reduction of granulocytes.
Jarstrand C; Ahlgren T; Berghem L
J Clin Lab Immunol; 1982 May; 8(1):59-63. PubMed ID: 7097752
[TBL] [Abstract][Full Text] [Related]
34. Effects of 2-deoxy-D-glucose on human monocyte metabolism and function.
Kay NE; Bumol TF; Douglas SD
J Reticuloendothel Soc; 1980 Oct; 28(4):367-79. PubMed ID: 7431370
[No Abstract] [Full Text] [Related]
35. [The immunomodulating action of bestatin in the combined therapy of bladder cancer patients].
Neprina GS; Panteleeva ES; Vatin OE; Kariakin OB
Urol Nefrol (Mosk); 1994; (2):34-8. PubMed ID: 8017004
[TBL] [Abstract][Full Text] [Related]
36. Defective activity of monocytes from patients with non-Hodgkin lymphoma. The modulatory effect of granulocyte-macrophage-colony stimulating factor.
Burgaleta C; Villalba S; González N
Cancer; 1999 Nov; 86(10):2133-7. PubMed ID: 10570442
[TBL] [Abstract][Full Text] [Related]
37. In vitro augmentation of cytotoxic activity of peripheral blood lymphocytes and spleen cells of cancer patients by ubenimex.
Iwahashi M; Tanimura H; Yamaue H; Tsunoda T; Tani M; Noguchi K; Mizobata S; Tamai M; Hotta T; Arii K
Anticancer Res; 1994; 14(4A):1557-62. PubMed ID: 7979185
[TBL] [Abstract][Full Text] [Related]
38. [Monocyte chemotaxis: critical evaluation of 2 methods of quantification].
Jiménez López A; Olmos Martínez JM; García Palomo JD; Sánchez Hernández JJ; De Dios Martín B; Pedraz García MJ
Allergol Immunopathol (Madr); 1984; 12(2):123-8. PubMed ID: 6380248
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-beta potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines.
Testa U; Masciulli R; Tritarelli E; Pustorino R; Mariani G; Martucci R; Barberi T; Camagna A; Valtieri M; Peschle C
J Immunol; 1993 Mar; 150(6):2418-30. PubMed ID: 8383719
[TBL] [Abstract][Full Text] [Related]
40. Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity.
Wiltschke C; Krainer M; Wagner A; Linkesch W; Zielinski CC
Exp Hematol; 1995 May; 23(5):402-6. PubMed ID: 7536681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
